Hello!

Neuropsychiatry team portal: www.eratne.net/portal

Website: www.neuropsychiatry.org.au
Twitter: www.twitter.com/NWMentalHealth
Publications: Full list on PubMed

The MiND Study – themindstudy.org

The Seminars in Neuropsychiatry: www.eratne.net/seminars

Neuropsychiatry Publications

Click here for the full list of publications on PubMed (currently only first author displays below, unfortunately)

• Carer burden and psychological distress in young-onset dementia: An Australian perspective
  June 16, 2022 by Matthew Kang
  OBJECTIVES: Carer burden in dementia is associated with poor outcomes, including early nursing home placement for people with dementia and psychological distress for their carers. Carers of people with young-onset dementia (YOD) are particularly vulnerable to carer burden. Yet they are often overlooked by clinicians as dementia services are generally designed for older people. We sought to estimate the rate of burden and psychological distress in carers of YOD at a state-wide tertiary service…
• Cortico-cognition coupling in treatment resistant schizophrenia
  June 11, 2022 by Warda T Syeda
  CONCLUSIONS: MB-PLS-C analyses identified multivariate brain structural-cognitive patterns in the latent space that may provide a TRS signature.
• The Lived Experiences of Depression in Huntington's Disease: A Qualitative Study
  May 16, 2022 by Hiba Bilal
  CONCLUSION: This study provides an enriched understanding of the unique characteristics of depression in HD, and the attributions that CAG expansion carriers make for their depression symptoms. The themes identified in this study can be used to guide more targeted assessment and treatment of depression in HD.
• A phase 1b open-label study of sodium selenate as a disease-modifying treatment for possible behavioral variant frontotemporal dementia
  May 16, 2022 by Lucy Vivash
  CONCLUSION: Sodium selenate is safe and well tolerated in patients with bvFTD. Randomized-controlled trials are warranted to investigate potential efficacy.
• Pineal morphology of the clinical high-risk state for psychosis and different psychotic disorders
  April 29, 2022 by Tsutomu Takahashi
  CONCLUSION: These results suggest that pineal atrophy is a general vulnerability marker of psychosis, while pineal cysts do not appear to contribute to the pathophysiology of psychosis.
• Music and Psychology & Social Connections Program: Protocol for a Novel Intervention for Dyads Affected by Younger-Onset Dementia
  April 21, 2022 by Samantha M Loi
  Psychosocial interventions targeting the specific needs of people affected by younger-onset dementia are lacking. Younger-onset dementia refers to dementia where symptom onset occurs at less than 65 years old. Because of its occurrence in middle age, the impact on spouses is particularly marked and dyadic-based interventions are recommended. Music And Psychology & Social Connections (MAPS) is a novel online intervention, informed by the theory of adaptive coping by Bannon et al. (2021) for dyads…
• Midsagittal corpus callosal thickness and cognitive impairment in Parkinson's disease
  March 11, 2022 by Conor Owens-Walton
  People diagnosed with Parkinson's disease (PD) can experience significant neuropsychiatric symptoms, including cognitive impairment and dementia, the neuroanatomical substrates of which are not fully characterised. Symptoms associated with cognitive impairment and dementia in PD may relate to direct structural changes to the corpus callosum via primary white matter pathology or as a secondary outcome due to the degeneration of cortical regions. Using magnetic resonance imaging, the corpus…
• Cerebrospinal fluid Alzheimer disease biomarkers for assessing cognitive and neuropsychiatric symptoms: Expanding the 'toolkit' in the psychiatrist's diagnostic armamentarium
  March 8, 2022 by Dhamidhu Eratne
  No abstract
• Clinico-demographics of people with younger-onset dementia and neuropsychiatric symptoms referred to an Australian dementia support service: A comparison study with older-onset dementia
  February 22, 2022 by Samantha M Loi
  CONCLUSION: Clinico-demographics of referrals with younger-onset dementia differ from those with older-onset dementia. There were some differences in the characteristics of neuropsychiatric symptoms between younger-onset dementia and older-onset dementia. Our findings have implications for service provision and support for people with dementia at different ages.
• Plasma neurofilament light chain protein is not increased in treatment-resistant schizophrenia and first-degree relatives
  February 18, 2022 by Dhamidhu Eratne
  CONCLUSION: Treatment-resistant schizophrenia does not appear to be associated with neuronal, particularly axonal degeneration. Further studies are warranted to investigate the utility of NfL to differentiate treatment-resistant schizophrenia from neurodegenerative disorders such as behavioural variant frontotemporal dementia, and to explore NfL in other stages of schizophrenia such as the prodome and first episode.

See more